135 related articles for article (PubMed ID: 35371322)
1. Tranexamic acid reduces endometrial cancer effects through the production of angiostatin.
Hiramoto K; Yamate Y
J Cancer; 2022; 13(5):1603-1610. PubMed ID: 35371322
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic Acid Ameliorates Nonmelanoma Skin Cancer Induced by Long-term Ultraviolet A Irradiation.
Hiramoto K; Yamate Y; Sugiyama D; Matsuda K; Iizuka Y; Yamaguchi T
Photochem Photobiol; 2019 Mar; 95(2):612-617. PubMed ID: 30267577
[TBL] [Abstract][Full Text] [Related]
3. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
Falcone DJ; Khan KM; Layne T; Fernandes L
J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Tranexamic Acid as an Anticancer Agent.
Law ME; Davis BJ; Ghilardi AF; Yaaghubi E; Dulloo ZM; Wang M; Guryanova OA; Heldermon CD; Jahn SC; Castellano RK; Law BK
Front Pharmacol; 2021; 12():792600. PubMed ID: 35095503
[TBL] [Abstract][Full Text] [Related]
5. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
6. The effect of hypoxia on plasma angiostatin and related factors in newborn pigs.
Emara M; Obaid L; Johnson S; Bigam DL; Cheung PY
Proc West Pharmacol Soc; 2007; 50():47-52. PubMed ID: 18605228
[TBL] [Abstract][Full Text] [Related]
7. Effect of tranexamic acid in improving the lifespan of naturally aging mice.
Hiramoto K; Yamate Y; Sugiyama D; Matsuda K; Iizuka Y; Yamaguchi T
Inflammopharmacology; 2019 Dec; 27(6):1319-1323. PubMed ID: 31236768
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic Acid Improves Memory and Learning Abilities in Aging Mice.
Hiramoto K; Yamate Y; Matsuda K; Sugiyama D; Iizuka Y
J Exp Pharmacol; 2020; 12():653-663. PubMed ID: 33376415
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
Patterson BC; Sang QA
J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
[TBL] [Abstract][Full Text] [Related]
10. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Joshi N; Kopec AK; Towery K; Williams KJ; Luyendyk JP
J Pharmacol Exp Ther; 2014 Jun; 349(3):383-92. PubMed ID: 24633426
[TBL] [Abstract][Full Text] [Related]
11. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells.
Martínez-Rizo A; Bueno-Topete M; González-Cuevas J; Armendáriz-Borunda J
Liver Int; 2010 Feb; 30(2):298-310. PubMed ID: 19889106
[TBL] [Abstract][Full Text] [Related]
12. Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
Mauceri HJ; Seetharam S; Beckett MA; Lee JY; Gupta VK; Gately S; Stack MS; Brown CK; Swedberg K; Kufe DW; Weichselbaum RR
Int J Cancer; 2002 Feb; 97(4):410-5. PubMed ID: 11802200
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
Cornelius LA; Nehring LC; Harding E; Bolanowski M; Welgus HG; Kobayashi DK; Pierce RA; Shapiro SD
J Immunol; 1998 Dec; 161(12):6845-52. PubMed ID: 9862716
[TBL] [Abstract][Full Text] [Related]
14. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.
Pozzi A; Moberg PE; Miles LA; Wagner S; Soloway P; Gardner HA
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2202-7. PubMed ID: 10681423
[TBL] [Abstract][Full Text] [Related]
15. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.
Binda MM; Matar P; González AD; Rozados VR; Gervasoni SI; Scharovsky OG; Bonfil RD
Int J Cancer; 2002 Jul; 100(1):14-21. PubMed ID: 12115581
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Niwa K; Murase T; Furui T; Morishita S; Mori H; Tanaka T; Mori H; Tamaya T
Jpn J Cancer Res; 1993 Sep; 84(9):951-5. PubMed ID: 8407561
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients.
Cao Y; Veitonmaki N; Keough K; Cheng H; Lee LS; Zurakowski D
Int J Mol Med; 2000 May; 5(5):547-51. PubMed ID: 10762660
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.
de Groot-Besseling RR; Ruers TJ; Lamers-Elemans IL; Maass CN; de Waal RM; Westphal JR
BMC Cancer; 2006 Jun; 6():149. PubMed ID: 16753063
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease.
Matsunaga T; Chilian WM; March K
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2042-6. PubMed ID: 15840902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
